RSS   Newsletter   Contact   Advertise with us
Post Online Media
Post Online Media Magazine

Cardiovascular disease costs in U.S. will exceed $1 trillion

Share on Twitter Share on LinkedIn
Staff Writer | February 15, 2017
Cardiovascular disease
Cost of health   CVD is the costliest disease in the U.S.

A new study by the American Heart Association projects that by 2035, cardiovascular disease (CVD) will place a crushing economic burden on the nation’s financial system.

According to the study, in the next two decades, the number of Americans with CVD will rise to 131.2 million – 45 percent of the total U.S. population – with costs expected to reach $1.1 trillion.

The new projections are an update of those made by the association in 2011 that estimated around 100 million Americans would suffer from CVD by 2030.

Unfortunately, that predication came true in 2015 – almost 15 years sooner than anticipated. That same year, the death rate from heart disease rose by 1 percent for the first time since 1969.

In addition to the staggering human toll it takes on Americans’ lives and health, CVD wreaks havoc on U.S. economy.

Currently, CVD is the costliest disease in the U.S., with a price tag of $555 billion in 2016. Yet, today’s study suggests that the economic burden of CVD will only get worse.

By 2035, costs will be in the trillions. Specifically, the total CVD costs across all conditions are projected to more than triple among those age 80+ and more than double among those ages 65-79.


What to read next
POST Online Media Contact